Discovery of Biomarkers for Endometrial Carcinoma
From LEAP
| Line 12: | Line 12: | ||
=== Reprint of Article === | === Reprint of Article === | ||
| - | [[Media:ASMS-poster2005Tim_new2.pdf]] | + | [[image: Info icon.png|40px]] [[Media:ASMS-poster2005Tim_new2.pdf | ASMS 2005 Poster]] |
---- | ---- | ||
| Line 21: | Line 21: | ||
For additional information about this technique please contact LEAP Technologies for detailed information | For additional information about this technique please contact LEAP Technologies for detailed information | ||
| - | + | [[image:Contact_Info.png|40px]] [http://www.leaptec.com/contact-us.php Contact the LEAP office] | |
<br><br> | <br><br> | ||
[[Category:Application Publications & Posters]] | [[Category:Application Publications & Posters]] | ||
| + | [[Category:MALDI]] | ||
Revision as of 16:20, 9 June 2009
Purpose: Discovering biomarkers for endometrial carcinoma rapidly by direct profiling of proteins in tissue sections.
Methods: nano-scale MALDI-Spotting and MALDI QqTOF mass spectrometry.
Results: Five up-regulated protein markers for endometrial carcinoma were discovered with the new tool.
Discovery of Biomarkers for Endometrial Carcinoma by Direct Profiling of Proteins in Tissue Sections Using Selective MALDI-SPOTTING and MALDI MS
Jingzhong Guo (1); Muntajib Alhaq (2); Leroi V. DeSouza (1); Gordon Nye (3); Werner Martin (3); Alexander D. Romaschin (4); Terence J. Colgan (2); K..W. Michael Siu (1) 1 York University, Toronto, ON, Canada; 2 Mount Sinai Hospital, Toronto, ON, Canada; 3 LEAP Technologies, Inc., Carrboro, NC; 4 Toronto General Hospital, Toronto, ON, Canada
Reprint of Article
Contact LEAP
For additional information about this technique please contact LEAP Technologies for detailed information
